Board of Directors

has been appointed as an executive Director and chairman of the Company and he is one of the co-founders of the Group. He was appointed a member of Remuneration Committee and Nomination Committee of the Company on 5 February 2018. Mr. Chen is also a director of all subsidiaries of the Company, including Futong Technology Co. Ltd. (“Futong BVI”), Etong Technology Holdings Limited, Futong Technology (HK) Company Limited, Futong Technology Development Holdings (HK) Limited, Futong Cloud Technology (HK) Company Limited, Futong Intelligent Health (HK) Company Limited, Beijing Futong Dongfang Technology Co., Ltd. (“Futong Dongfang”), Futong Times Technology Co., Ltd. (“Futong Times”), Beijing Etong Dongfang Technology Co., Ltd. (“Etong Dongfang”). Futong Cloud Technology Co., Ltd (“Futong Cloud”) and Beijing Futong Intelligent Health Technology Co., Ltd. (“Futong Intelligent”). Mr. Chen is responsible for the strategic development and the Group’s business direction, and overseeing the self-developed products business. He has over 35 years of experience in IT industry. Mr. Chen graduated from 中國人民解放軍通信工程學院 (Chinese People’s Liberation Army Communication Engineering University) with a bachelor’s degree in wireless communications engineering.

has extensive experience in artificial intelligence, big data and cloud computing. She served as a director of ecosystem in Futong Cloud Technology Co., Ltd.* (富通雲騰科技有限公司), a subsidiary of the Group, from 2019 to 2021. She was responsible for product operations in Beijing Futong Intelligent Health Technology Co., Ltd.* (北京富通智康科技有限公司), a subsidiary of the Group, from 2021 to 2023. She has been the operations director of Hong Kong Beijing Applied Science Innovation Center Limited (港京應用科技創新中心有限公司) and the chief operations officer of the Company since 2023. She is a member of the Chinese Association for Artificial Intelligence.

was appointed as an independent non-executive Director on 1 December 2016. He was a partner of VMS Investment Group, which is a multi-strategies investment house. Mr. Chow was formerly the chairman of the Mainland Development Strategies Advisory Panel of the Hong Kong Institute of Certified Public Accountants, a member of the Investment Advisory Committee of the Hong Kong Institute of Chartered Secretaries (currently known as the Hong Kong Chartered Governance Institute) and a member of both of the Listing Committee of the Stock Exchange and the Dual Filing Advisory Group of the Securities and Futures Commission. Mr. Chow is a fellow member of the Hong Kong Institute of Certified Public Accountants, the Institute of Chartered Secretaries and Administrators and the Hong Kong Chartered Governance Institute. Mr. Chow had been working with one of the four largest certified public accounting firms in the world as a partner for many years. He has an indepth knowledge on the accounting standards and business regulations in Hong Kong. Mr. Chow has been serving as an independent non-executive director of AGTech Holdings Limited (stock code: 08279), Genertec Universal Group Company Limited (stock code: 02666), China Everbright Greentech Limited (stock code: 01257) and China Tobacco International (HK) Company Limited (stock code: 06055), the shares of which are listed on the Stock Exchange. In the last three years, he was an independent non-executive director of Shanghai Dazhong Public Utilities (Group) Co., Ltd. (stock code: 01635) from April 2016 to May 2022 and Fullshare Holdings Limited (stock code: 00607) from December 2013 to December 2021, and a non-executive director of Renrui Human Resources Technology Holdings Limited (stock code: 06919) from July 2018 to April 2023, the shares of which are listed on the Stock Exchange, and was an independent non-executive director of Global Cord Blood Corporation (stock code: NYSE: CO) from November 2019 to October 2022, a company listed on the New York Stock Exchange.

was appointed as an independent non-executive Director on 5 February 2018. He is a partner in a law firm in Hong Kong and has been practising as a solicitor in Hong Kong for over 30 years. Mr. Lo holds the degrees of Bachelor of Laws and Bachelor of Jurisprudence from the University of New South Wales, Australia. He was admitted as a solicitor of the Supreme Court of New South Wales, Australia in 1984. Mr. Lo has been a member of The Law Society of Hong Kong since 1987. Mr. Lo is currently an independent nonexecutive director of each of eSun Holdings Limited (stock code: 00571) and Man Yue Technology Holdings Limited (stock code: 00894). All the above companies are listed on the Stock Exchange.

was appointed as an independent non-executive Director on 25 May 2018. He holds the Graduate Diploma of Management from the Central Queensland University, Australia. Mr. Yao has in depth knowledge in machinery equipment, intelligence devices and IDC centers operations. He has over 20 years’ experience in the role of executive directors in various companies. Mr. Yao is currently the executive director of 先控捷聯電氣股份有限公司 (stock code: 833426), a company listed on the National Equities Exchange and Quotations system in the People’s Republic of China.